Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML
Clinical trial NCT02891278 · COMPLETED
Trial details
- NCT number
- NCT02891278
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-11
- Primary completion
- 2020-11-17
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.